| B cells are the dominant antigen-presenting cells that activate naive CD4+ T cells upon immunization with a virus-derived nanoparticle antigen S Hong, Z Zhang, H Liu, M Tian, X Zhu, Z Zhang, W Wang, X Zhou, ... Immunity 49 (4), 695-708. e4, 2018 | 255 | 2018 |
| Intratumoral stem-like CCR4+ regulatory T cells orchestrate the immunosuppressive microenvironment in HCC associated with hepatitis B Y Gao, M You, J Fu, M Tian, X Zhong, C Du, Z Hong, Z Zhu, J Liu, ... Journal of Hepatology 76 (1), 148-159, 2022 | 86 | 2022 |
| B cell–intrinsic MyD88 signaling promotes initial cell proliferation and differentiation to enhance the germinal center response to a virus-like particle M Tian, Z Hua, S Hong, Z Zhang, C Liu, L Lin, J Chen, W Zhang, X Zhou, ... The Journal of Immunology 200 (3), 937-948, 2018 | 49 | 2018 |
| An optimized bicistronic chimeric antigen receptor against GPC2 or CD276 overcomes heterogeneous expression in neuroblastoma M Tian, AT Cheuk, JS Wei, A Abdelmaksoud, HC Chou, D Milewski, ... The Journal of Clinical Investigation 132 (16), 2022 | 39 | 2022 |
| Recombinant Newcastle disease viral vector expressing hemagglutinin or fusion of canine distemper virus is safe and immunogenic in minks J Ge, X Wang, M Tian, Y Gao, Z Wen, G Yu, W Zhou, S Zu, Z Bu Vaccine 33 (21), 2457-2462, 2015 | 39 | 2015 |
| Novel in-ovo chimeric recombinant Newcastle disease vaccine protects against both Newcastle disease and infectious bursal disease J Ge, X Wang, M Tian, Z Wen, Q Feng, X Qi, H Gao, X Wang, Z Bu Vaccine 32 (13), 1514-1521, 2014 | 37 | 2014 |
| CAR T cells targeting tumor-associated exons of glypican 2 regress neuroblastoma in mice N Li, MB Torres, MR Spetz, R Wang, L Peng, M Tian, CM Dower, ... Cell Reports Medicine 2 (6), 2021 | 29 | 2021 |
| Targeting histone deacetylase 6 reprograms interleukin‐17‐producing helper T cell pathogenicity and facilitates immunotherapies for hepatocellular carcinoma W Qiu, B Wang, Y Gao, Y Tian, M Tian, Y Chen, L Xu, TP Yao, P Li, ... Hepatology 71 (6), 1967-1987, 2020 | 23 | 2020 |
| SARS-CoV-2 protein ORF3a is pathogenic in Drosophila and causes phenotypes associated with COVID-19 post-viral syndrome S Yang, M Tian, AN Johnson bioRxiv 10 (2020.12), 20.423533, 2020 | 17 | 2020 |
| A stem cell epigenome is associated with primary nonresponse to CD19 CAR T cells in pediatric acute lymphoblastic leukemia KE Masih, RA Gardner, HC Chou, A Abdelmaksoud, YK Song, L Mariani, ... Blood Advances 7 (15), 4218-4232, 2023 | 8 | 2023 |
| Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma M Tian, JS Wei, N Shivaprasad, SL Highfill, BE Gryder, D Milewski, ... Cell Reports Medicine 4 (10), 2023 | 5 | 2023 |
| Suppression of antigen presentation is a hallmark of pediatric rhabdomyosarcoma D Milewski, M Tian, Y Kim, J Wei, J Khan Cancer Research 83 (7_Supplement), 6736-6736, 2023 | 1 | 2023 |
| Infection and chronic disease activate a brain-muscle signaling axis that regulates muscle performance S Yang, M Tian, Y Dai, S Feng, Y Wang, D Chhangani, T Ou, W Li, Z Yang, ... bioRxiv, 2020 | 1 | 2020 |
| Abstract LB042: A potent FGFR4-targeted antibody-drug conjugate therapy for patients with rhabdomyosarcoma and other cancers expressing FGFR4 M Tian, K Jia, JT Wu, JS Wei, AT Cheuk, Z Zhang, EG Pope, B Shor, ... Cancer Research 84 (7_Supplement), LB042-LB042, 2024 | | 2024 |
| Abstract LB403: Suppression of antigen presentation in pediatric rhabdomyosarcoma D Milewski, HC Chou, V Gangalapudi, M Tian, Y Kim, Y Song, J Wei, ... Cancer Research 84 (7_Supplement), LB403-LB403, 2024 | | 2024 |
| Genome-Wide CRISPR gene knockout screens combined with selpercatinib identifies potent combination therapies for RET driven medullary thyroid carcinoma A Rahmy, A Fallatah, D Milewski, M Tian, Y Song, Y Kim, HC Chou, ... Cancer Research 84 (6_Supplement), 5835-5835, 2024 | | 2024 |
| FGFR4 and CD276 dual targeting CAR T cells demonstrate synergistic antitumor activity in childhood rhabdomyosarcoma M Tian, JS Wei, A Cheuk, D Milewski, Z Zhang, YY Kim, C Liu, S Badr, ... Cancer Research 83 (7_Supplement), 1784-1784, 2023 | | 2023 |
| FGFR4 and CD276 dualtargeting CAR-T cells for treating rhabdomyosarcoma and other solid tumors M Tian, A Cheuk, D Milewski, JS Wei, HC Chou, YY Kim, YK Song, ... Cancer Research 82 (12_Supplement), 552-552, 2022 | | 2022 |
| Abstract LB213: Potent antitumor activity of a FGFR4 CAR-T in rhabdomyosarcoma ATC Cheuk, M Tian, N Shivaprasad, S Highfill, D Milewski, GT Brown, ... Cancer Research 82 (12_Supplement), LB213-LB213, 2022 | | 2022 |
| Potent tumoricidal activity of a FGFR4 CART in rhabdomyosarcoma A Cheuk, M Tian, J Kumar, P Azorsa, N Shivaprasad, D Schneider, ... Cancer Research 81 (13_Supplement), 1885-1885, 2021 | | 2021 |
